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Abstract
Accumulation of high levels of unintegrated viral DNA is a common feature of retroviral infection.
It was recently discovered that coinfection of cells with integrated and unintegrated HIV-1 can
result in complementation, allowing viral replication in the absence of integration. This new mode
of HIV-1 replication has numerous implications for the function of unintegrated viral DNA and its
application as a therapeutic vector.
Introduction
With retroviruses such as HIV, life seems to be simple and
straightforward. As a single infectious particle, the virus
converts its RNA genome into DNA and then incorporates
it into the host genome. Once this happens, the rest of the
viral life cycle is largely a happy free ride from the host.
However, for the viral population as a whole, the truth is
that only a very small proportion of the viruses have such
a productive life. The vast majority of the viral DNA
remains isolated from the host chromatin [1-8]. These
DNA molecules are euphemistically referred to as the
"unintegrated"; in reality, they are the "left behind" and
down regulated (gene expression is low and restricted to
only early genes [9-11]). The stakes are high; they are at
risk of being destroyed and cleared [12,13]. We still do not
understand why most HIV DNA cannot or does not inte-
grate, and other questions remain as well: is there some-
thing wrong with these "unintegrated," and do they
deserve a second chance?
Answering these questions is not as simple as it seems.
First, within a viral population, we do not know which
viral DNA is destined to integrate, and there is no marker
to differentiate this phenotype. Second, against a back-
ground of viral activities from both the integrated and the
unintegrated, it is difficult to monitor and track viral
behavior from the unintegrated alone. In spite of these
hurdles, in the recent article by Gelderblom and co-
authors [14], these questions were elegantly addressed
using a very creative approach. The authors employed
coinfection of cells with the wild-type virus and an inte-
grase mutant, both of which were labelled with different
fluorescent reporters. This permitted tracking and delicate
differentiation of the wild-type and the unintegrated
viruses.
To address the question of whether the unintegrated viral
DNA remains functional, the authors used an integrase
inhibitor and an integrase mutant virus, D116N [15].
They also tagged the viral early genes with green fluores-
cent protein (GFP) and a late gene with murine Heat Sta-
ble Antigen (HSA). When cells were infected with D116N,
or with the wild-type virus in the presence of the integrase
inhibitor, approximately 25% of the cells expressed low
levels of viral genes from the unintegrated DNA, in com-
parison with cells infected with only the wild-type virus.
The authors also found that 96% of the D116N-infected,
GFP+ cells expressed only the early genes. These results are
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consistent with previous findings that unintegrated virus
can transcribe both the early (multiply spliced) and late
(partially spliced and unspliced) genes, but only the early
genes are measurably translated due to a lack of sufficient
Rev function [9-11].
Remarkably, when the DsRedX-labelled wild-type virus
was used to coinfect with the GFP-labelled D116N, the
authors were able to demonstrate that the wild-type virus
can chase a large amount of unintegrated HIV DNA into
active templates through the stimulatory effect of Tat.
Additionally, the wild-type virus can even drive the unin-
tegrated viral DNA to express late genes through the action
of Rev. Furthermore, the RNA genome transcribed from
the unintegrated DNA can be packaged into the virion and
is able to effectively compete with the wild-type genome
for packaging. These results clearly suggest that the unin-
tegrated DNA molecules have the full potential in this
regard of any HIV DNA. Their limitations in expressing
viral genes appear to be only temporary, imposed by the
lack of sufficient Tat and Rev function.
With this understanding of their full potential, the next
question of whether these unintegrated DNA molecules
deserve a second chance becomes obvious. Yes, they do!
Indeed, the authors confirmed that in the presence of the
second virus, the unintegrated HIV DNA molecules were
driven to express both early and late genes, as well as viral
genomes that were subsequently packaged and released
from the cell. They thus started on a new journey that gave
them a second opportunity to integrate. As the authors
concluded, this complementation between the few inte-
grated and the majority unintegrated would prevent pos-
sible losses of viral genetic diversity.
Discussion
Extrapolating from this modelling study, we can imagine
three different scenarios in which the unintegrated viral
DNA might contribute to a productive viral replication
cycle. As shown in Figure 1A, during primary infection, in
some situations where integration is restricted, because of
either cellular restrictions or unknown viral processes, the
unintegrated HIV DNA can still synthesize low levels of
Model of complementation between unintegrated and integrated HIV-1 Figure 1
Model of complementation between unintegrated and integrated HIV-1. (A) Viral transcription in the absence of 
integration generates all classes of viral transcripts, but only early proteins such as Tat, Rev, and Nef are synthesized at low lev-
els. Tat and Nef can modulate cellular conditions. Viral replication does not occur without integration, but infection by a sec-
ond virus can rescue the unintegrated viral genomes. (B) Coinfection of a cell by multiple particles can lead to accumulation of 
unintegrated viral DNA. However, an integrated provirus can rescue the genomes of the unintegrated viral DNA, preventing 
possible losses of viral genetic diversity. (C) Superinfection of a productively infected cell may not require new integration of 
the incoming virus, thus reducing steps required for viral replication and avoiding excessive integration to disrupt cellular func-
tion.
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early proteins such as Tat, Rev, and Nef [9-11,16,17]. Both
Tat and Nef can modulate T cell activity to facilitate acti-
vation [9,18-21]. In particular, Nef does not increase the
extent of T cell activation; it only increases the number of
T cells that can be activated [9,19-21]. This would expand
cellular targets for viral infection, since a lot more cells are
available for productive viral replication. In resting T cells
cultured in vitro, viral DNA synthesis maximizes at
around 2 days post infection, and the unintegrated viral
DNA has a half life of about 1 to 2 days [12,13]. Some of
the viral DNA may remain rescuable for weeks, since pro-
ductive viral replication can be initiated with T cell activa-
tion [9,13,22-26]. In human macrophages, the
unintegrated viral DNA can persist for as long as 30 days
[11]. It is unlikely that the unintegrated DNA can still inte-
grate after a certain time when the preintegration complex
is disassembled. Nevertheless, the unintegrated DNA may
still be rescuable by a second virus. In this sense, the unin-
tegrated viral DNA would also constitute a viral reservoir.
Certainly, the presence of such unintegrated reservoir has
been detected in most of untreated HIV patients and in
some of the infected patients on highly active antiretrovi-
ral therapy (HAART) [27]. This unintegrated reservoir is
labile, but is inducible and functional even in some
HAART-treated patients [27].
The unintegrated viral DNA molecules do not simply wait
for the rescuer; they also actively synthesize early proteins
such as Tat and Nef to modulate cellular conditions. To be
rescued, the unintegrated DNA has to meet several condi-
tions. First, its low-level viral activity should not kill the
cell carrying the unintegrated viral DNA. Second, it should
prime a cellular condition that favors the second virus
after the initial integration attempt fails. This would
ensure that the rescuer would not be trapped in the same
situation. Third, although perfect fitness is not required,
any rescuable virus should have a selective advantage
equal or better than that of the rescuer, in terms of the
ability to compete for packaging and promoting favorable
cellular conditions. One remaining issue for this scenario,
however, is whether the unintegrated virus may prevent
secondary infection. Although Nef expressed from uninte-
grated DNA can also down-modulate CD4 [17], it is
unlikely that the down-modulation can reach such a
severity that it completely prevents superinfection [28].
In the second scenario (Figure 1B), where local virus con-
centrations are high, multiple coinfection of a cell, such as
the infection of cells in lymphoid tissues, may occur. In
this case, not every virus can integrate, and if some viruses
fail, an integrated virus within the same cell would be able
to rescue and complement the unintegrated viruses, pre-
venting possible dwindling of the viral genetic repertoire
[14]. HIV coinfection is also an important source of viral
recombination which may increase the fitness of the virus
[29]. Coinfection is certainly detected frequently in
patients and is known to contribute to viral genetic diver-
sity [29].
In the third scenario (Figure 1C), it is also possible that
superinfection of an already productively infected cell
may not always require new integration for the incoming
virus. The incoming HIV DNA could be quickly used to
express viral genes and be assembled into virion particles,
with the help of Tat, Rev, and the assembly factors from
the integrated provirus. This would facilitate viral replica-
tion and avoid excessive integration that disrupts cellular
functions.
In the Gelderblom et al. study [14], the use of fluorescent
reporters had a clear advantage for differentiating various
viral and cell populations. An unexpected, striking finding
is that although the integrated provirus can chase out
many "silent" unintegrated DNA templates, the expres-
sion levels from the unintegrated can never match those
from the integrated proviruses. There is a clear distinction
between these two types of viral DNA templates. Cer-
tainly, the possible regulatory mechanism for this differ-
ence is of potential interest in the future. Using
fluorescent reporters also has its downside: the low sensi-
tivity of fluorescent reporters dictates that a large number
of molecules must accumulate in order to be detectable by
flow cytometry. This may lead to underestimation of the
number of active, unintegrated DNA templates. Some of
these "silent" DNA molecules may not be absolutely
quiet; instead, it is likely that they actively transcribe, but
at a low level "under the radar."
There was also a remote possibility that in the Gelderb-
lom's coinfection experiment, D116N could have inte-
grated with the integrase provided in trans by a
coinfecting wild-type virus. However, it is difficult to
imagine that the D116N preintegration complex (PIC)
could have been disassembled first and then reassembled
with a new wild-type PIC. Additionally, during coinfec-
tion with the wild-type virus, although the number of
active templates was increased, the level of gene expres-
sion from D116N was distinctively low, similar to that
from the single infection by D116N. This result indicated
that the templates were different from the integrated pro-
viral DNA and were likely from the unintegrated.
Conclusion
Recent years have witnessed an increasing number of
studies characterizing unintegrated HIV-1 DNA [9-
11,16,17,30,31]. It has become clear that the viral activi-
ties from unintegrated DNA are not merely an irrelevant
phenomenon distinct from the dominant productive viral
replication cycle produced from the integrated proviruses.
As demonstrated recently [9,14,16], these two virologicalRetrovirology 2008, 5:61 http://www.retrovirology.com/content/5/1/61
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processes are intimately intertwined to facilitate viral
infection and to overcome certain cellular hurdles. Of
course, many fundamental questions remain to be
addressed. We still do not understand why most of the
viral DNA molecules do not integrate. We also do not
know how transcription prior to integration is directly
linked with the sequential steps of the viral replication
process. Nevertheless, the limited information obtained
from basic research on unintegrated DNA does not appear
to contradict the recent interest in using unintegrated len-
tivirus for gene therapy and as attenuated vaccines [32-
35]. With additional studies of this biological process, we
can look forward to more interesting stories from these
"unintegrated."
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